Ashkenazi's appointment will take effect on July 31, with Porat remaining as CFO until then. Ashkenazi's tenure at Eli Lilly saw the launch of several successful treatments and a significant increase in the company's share price. Alphabet's shares rose 0.8% in premarket trading following the announcement, while Eli Lilly's shares dipped 0.3%.
Key takeaways:
- Anat Ashkenazi has been appointed as the new Chief Financial Officer of Alphabet Inc., replacing Ruth Porat.
- Ashkenazi brings over two decades of experience from Eli Lilly, where she held key positions including finance chief and controller of Lilly Research Laboratories.
- The appointment comes as Alphabet Inc. is heavily investing in AI technologies to stay competitive in the tech industry.
- Ashkenazi's appointment will take effect on July 31, with Porat remaining as CFO until then.